Clinical Trials in Baltimore

Showing 22521-22540 of 23,476 trials

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

NCT00411723

RTL1000 is a new agent that has not been previously tested in humans. It is thought that RTL may specifically control the abnormal immune response or attack against the insulation on the nerves that occurs in multiple sclerosis. The purpose of this study is to evaluate the possible side effects of a single intravenous dose of RTL1000 in subjects with multiple sclerosis. Some subjects will also be asked to participate in one or both of two substudies, one to test blood samples to see how the body's immune system responds after administration of RTL1000, and the other to test blood samples to see how the body absorbs and eliminates the RTL1000.

Multiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-Remitting

Artielle ImmunoTherapeutics34 participantsStarted Dec 2006

New Haven, Connecticut, United States • Indianapolis, Indiana, United States • Kansas City, Kansas, United States +3 more locations

COMPLETEDPhase 1< 1 mile

Carmustine in Treating Patients With Recurrent Malignant Glioma

NCT00004028

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of carmustine in treating patients who are undergoing surgery for recurrent malignant glioma.

Brain and Central Nervous System Tumors

National Cancer Institute (NCI)Started Sep 1996

Birmingham, Alabama, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +6 more locations

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Carmustine in Treating Patients With Recurrent Malignant Glioma

Find Trials by Condition in Baltimore

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

Cardiac Arrest Recovery EEG Study

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

CPG 7909 Injection in Non-Small Cell Lung Cancer

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes